Toxic effects of human eosinophil products on isolated rat heart cells in vitro.
about
Eosinophils in infection and intestinal immunityDeposition of eosinophil cationic protein in granulomas in allergic granulomatosis and vasculitis: the Churg-Strauss syndrome.Deposition of eosinophil cationic protein in vascular lesions in temporal arteritis.Eosinophils in Autoimmune Diseases.Recent advances in eosinophil biology.Tumor necrosis factor enhances eosinophil toxicity to Schistosoma mansoni larvae.Eosinophils and the pathophysiology of allergic rhinitis.Eosinophilic myocarditis in CBA/J mice infected with Toxocara canis.Eosinophilic myocarditis: case series and review of literature.Acute necrotising eosinophilic myocarditisThoughts on the complex relationship between gastroesophageal reflux disease and eosinophilic esophagitis.Major basic protein-1 promotes fibrosis of dystrophic muscle and attenuates the cellular immune response in muscular dystrophy.Functional role of eosinophils in gastrointestinal inflammation.Biology of the eosinophilTargeting eosinophils in allergy, inflammation and beyond.The cardiotoxicity of eosinophils.Eosinophilic esophagitis: interactions with gastroesophageal reflux disease.Eosinophilic disorders affecting the myocardium and endocardium: a review.The hypereosinophilic syndrome: clinical features, laboratory findings and treatment.Myopericarditis in Churg-Strauss syndrome.The spectrum of eosinophilic myositis. Clinical and immunopathogenic studies of three patients, and review of the literature.A Case of Loeffler's Endocarditis Associated with Churg-Strauss Syndrome.The pathogenesis of eosinophilic endomyocardial disease in patients with carcinomas of the lung.Eosinophil-derived IL-4 drives progression of myocarditis to inflammatory dilated cardiomyopathy.Interaction and complex-formation between the eosinophil cationic protein and alpha 2-macroglobulin.Control of hypereosinophilic syndrome-associated recalcitrant coronary artery spasm by combined treatment with prednisone, imatinib mesylate and hydroxyurea.Human muscle protein degradation in vitro by eosinophil cationic protein (ECP).Eosinophil activation in systemic sclerosis.Macrophages and cardiac fibroblasts are the main producers of eotaxins and regulate eosinophil trafficking to the heart.Immunohistochemical differentiation of eosinophilic heart diseases using antibodies against eosinophil activation markers.Improvement of eosinophilic heart disease after steroid therapy: successful demonstration by endomyocardial biopsied specimens.The idiopathic hypereosinophilic syndromeImmunohistochemical detection of deposits of eosinophil-derived neurotoxin and eosinophil peroxidase in the myocardium of patients with Chagas' disease
P2860
Q27028076-67F7C600-9EC2-4AC4-8D13-656361981623Q33391117-766996CA-F98D-42AB-BE00-4FF35E4CFE7CQ33564116-3BAFCE59-9077-450B-8489-3EC4F3670720Q33607031-43481893-8E3F-46E6-9F29-AE98B98D9E1DQ34579906-71B36BCB-B476-4E6F-97A5-3418076EC1C2Q35590901-385559F8-49BA-4CF1-95C2-740CB2C2DC49Q35660133-08824697-46C1-4288-8C6D-E314980AE439Q35811233-74C241A0-A698-44B6-8674-CE7973A61A45Q36676094-C21FF0FF-08A4-43BE-A51E-E0F3F621B087Q36752295-C9379A3D-7D20-4E2F-9CD3-F5FF908A81F2Q36832496-381DE0E5-0BD0-45D4-9511-4C6C025E4857Q36952488-C8A7D625-5C04-4199-8BC0-EC718A463DABQ37367619-160FAE49-36FA-419E-B239-8CC51FBBA24CQ37397520-20689318-43F9-49D7-9E82-04247CD50CD3Q38075409-F9F93741-1CAC-4249-AAD9-295930C9776AQ38928292-C9844144-AD14-41EF-80C8-A0A71A3C83CAQ39576931-DEAD0DEF-1DE2-4560-9169-D9F21B2D142EQ39844296-84DAB577-312E-4702-B0C0-8D3A4CE1DCFAQ40250375-F0FC8CE4-E11B-4606-B605-387D10CA2BB5Q40486097-4EBB7870-4AFF-4510-8225-2049EBDF27FDQ40819179-4FC233E5-3B64-4746-A338-B4A6881259A9Q41252621-CA05E561-83CC-4373-B98B-97D17A9AE2CFQ41481511-4653AA38-14D5-4196-B8B5-122E3EE122D6Q41874438-E4FE8DBC-AD32-48F3-ABA0-FE3FE4E1B0B8Q42856500-4D22FFF4-72BD-4992-A366-E7582AAB4F66Q43087340-98C1D1E3-A0C3-4318-9004-AA67259F2E5DQ43824986-B6356A76-8229-44A1-867A-D83F4E157542Q45283754-ED029479-8156-4D9E-B79C-FA6BEC1772A5Q51514876-BDEFDE15-B41C-4EC0-90B6-A6C9E5D3FA2CQ51552201-2D45B696-8445-4924-AA61-BA81F511EABBQ52537837-6282911F-FE8F-42AF-BB1A-2674B5474E44Q57656948-620A975B-87A9-4153-BA73-E7B44751D432Q58845651-0390132A-0ABE-446B-8A52-26107CA35EC9
P2860
Toxic effects of human eosinophil products on isolated rat heart cells in vitro.
description
1982 nî lūn-bûn
@nan
1982年の論文
@ja
1982年論文
@yue
1982年論文
@zh-hant
1982年論文
@zh-hk
1982年論文
@zh-mo
1982年論文
@zh-tw
1982年论文
@wuu
1982年论文
@zh
1982年论文
@zh-cn
name
Toxic effects of human eosinophil products on isolated rat heart cells in vitro.
@en
Toxic effects of human eosinophil products on isolated rat heart cells in vitro.
@nl
type
label
Toxic effects of human eosinophil products on isolated rat heart cells in vitro.
@en
Toxic effects of human eosinophil products on isolated rat heart cells in vitro.
@nl
prefLabel
Toxic effects of human eosinophil products on isolated rat heart cells in vitro.
@en
Toxic effects of human eosinophil products on isolated rat heart cells in vitro.
@nl
P2093
P2860
P356
P1433
P1476
Toxic effects of human eosinophil products on isolated rat heart cells in vitro.
@en
P2093
P2860
P356
10.1042/BJ2040075
P407
P577
1982-04-01T00:00:00Z